HK36593A - Use of ketone derivatives in the treatment of depression - Google Patents

Use of ketone derivatives in the treatment of depression

Info

Publication number
HK36593A
HK36593A HK365/93A HK36593A HK36593A HK 36593 A HK36593 A HK 36593A HK 365/93 A HK365/93 A HK 365/93A HK 36593 A HK36593 A HK 36593A HK 36593 A HK36593 A HK 36593A
Authority
HK
Hong Kong
Prior art keywords
depression
treatment
ketone derivatives
methyl
ketone
Prior art date
Application number
HK365/93A
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK36593A publication Critical patent/HK36593A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
HK365/93A 1986-12-17 1993-04-15 Use of ketone derivatives in the treatment of depression HK36593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
HK36593A true HK36593A (en) 1993-04-23

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
HK365/93A HK36593A (en) 1986-12-17 1993-04-15 Use of ketone derivatives in the treatment of depression

Country Status (18)

Country Link
US (1) US4835173A (ja)
EP (1) EP0276559B1 (ja)
JP (1) JP2732844B2 (ja)
KR (1) KR880007073A (ja)
AT (1) ATE79031T1 (ja)
AU (1) AU608794B2 (ja)
CY (1) CY1693A (ja)
DE (1) DE3780940T2 (ja)
DK (1) DK662787A (ja)
ES (1) ES2051754T3 (ja)
GB (1) GB8630071D0 (ja)
GR (1) GR3005682T3 (ja)
HK (1) HK36593A (ja)
IE (1) IE60135B1 (ja)
IL (1) IL84844A0 (ja)
NZ (1) NZ222949A (ja)
PH (1) PH25503A (ja)
ZA (1) ZA879458B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278173B1 (en) * 1986-12-17 1993-11-03 Glaxo Group Limited Use of heterocyclic derivatives in the treatment of depressions
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
JP2002538102A (ja) 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
IL156835A0 (en) * 2001-01-11 2004-02-08 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
US7098345B2 (en) * 2002-04-29 2006-08-29 TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
DE20320528U1 (de) * 2002-04-30 2004-09-16 Teva Pharmaceuticals Usa, Inc. Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
WO2009027564A1 (es) * 2007-08-08 2009-03-05 Legarda Ibanez Juan Jose Uso y métodos de uso de un antagonista del receptor (5-ht3) de la serotonina3 y un modulador selectivo de los canales de cloruro para el tratamiento de la adicción a o la dependencia de fármacos/drogas o trastornos del sistema nervioso central
JP7410055B2 (ja) * 2018-06-21 2024-01-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ニコチンアミドアデニンジヌクレオチド（ｎａｄ＋）前駆体及び少なくとも１種のケトン又はケトン前駆体を使用する組成物及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (ja) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
NL190373C (nl) * 1984-01-25 1994-02-01 Glaxo Group Ltd Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol

Also Published As

Publication number Publication date
EP0276559A2 (en) 1988-08-03
AU8261787A (en) 1988-06-23
CY1693A (en) 1994-01-14
IL84844A0 (en) 1988-06-30
NZ222949A (en) 1997-06-24
AU608794B2 (en) 1991-04-18
PH25503A (en) 1991-07-24
ATE79031T1 (de) 1992-08-15
GB8630071D0 (en) 1987-01-28
IE873415L (en) 1988-06-17
JP2732844B2 (ja) 1998-03-30
EP0276559B1 (en) 1992-08-05
IE60135B1 (en) 1994-06-01
DK662787A (da) 1988-06-18
JPS63165314A (ja) 1988-07-08
GR3005682T3 (ja) 1993-06-07
DE3780940D1 (de) 1992-09-10
EP0276559A3 (en) 1989-10-18
DK662787D0 (da) 1987-12-16
ES2051754T3 (es) 1994-07-01
ZA879458B (en) 1988-11-30
KR880007073A (ko) 1988-08-26
DE3780940T2 (de) 1992-12-24
US4835173A (en) 1989-05-30

Similar Documents

Publication Publication Date Title
EP0276559A3 (en) Use of ketone derivatives in the treatment of depression
SE8503680L (sv) Indolderivat
NO873695D0 (no) Dentalt implantat av skruetypen og fremgangsmaate for bruk av samme.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
NO911432L (no) Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.
IE873414L (en) Medicament for dementia
GR3004252T3 (ja)
NO893826D0 (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
GR3003327T3 (en) Substituted 1,8-naphthyridine derivatives and fungicides containing them
EP0167995A3 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
FR2630907B1 (fr) Cotyle visse, notamment pour prothese du type " de hanche "
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
IE873231L (en) Medicaments
GR74782B (ja)
EP0729740A3 (de) Verwendung von Goldlegierungen für Konstruktionselemente in der Dentaltechnik
ZA874878B (en) Pyran derivatives
NZ223203A (en) Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
CS310487A1 (en) Connection for amplifier's output stage's transistor operating point adjustment
MY102564A (en) An indole derivative
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041216